Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural insights into NMDA receptor pharmacology
Changping Zhou, N. Tajima
Biochemical Society Transactions (2023) Vol. 51, Iss. 4, pp. 1713-1731
Open Access | Times Cited: 19

Showing 19 citing articles:

NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders
Ayodeji O. Egunlusi, Jacques Joubert
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 639-639
Open Access | Times Cited: 15
Molecular mechanism of ligand gating and opening of NMDA receptor
Tsung‐Han Chou, Max Epstein, Russell G. Fritzemeier, et al.
Nature (2024) Vol. 632, Iss. 8023, pp. 209-217
Closed Access | Times Cited: 11
Structure and function of GluN1-3A NMDA receptor excitatory glycine receptor channel
Kevin Michalski, Hiro Furukawa
Science Advances (2024) Vol. 10, Iss. 15
Open Access | Times Cited: 6
GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases
Amany Digal Ladagu, Funmilayo Eniola Olopade, Adeboye Adejare, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1535-1535
Open Access | Times Cited: 13
Disruptions in cellular communication: Molecular interplay between glutamate/NMDA signalling and MAPK pathways in neurological disorders
Sumedha Gupta, Abhishek Gupta, Sidharth Mehan, et al.
Neuroscience (2025)
Closed Access
Design of (R)-3-(5-Thienyl)carboxamido-2-aminopropanoic Acid Derivatives as Novel NMDA Receptor Glycine Site Agonists: Variation in Molecular Geometry to Improve Potency and Augment GluN2 Subunit-Specific Activity
Fabao Zhao, Unai Atxabal, Sofia Mariottini, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Future Perspectives of NMDAR in CNS Disorders
Toni Capó, Joan Biel Rebassa, Iu Raïch, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 877-877
Open Access
Neurotoxicity mechanisms and clinical implications of six common recreational drugs
Jing Wang, Yulei Hao, Ma Di, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Effect of SSR504734, a Selective Glycine Transporter Type 1 Inhibitor, on Seizure Thresholds, Neurotransmitter Levels, and Inflammatory Markers in Mice
Nikola Gapińska, Piotr Właź, Elżbieta Wyska, et al.
ACS Chemical Neuroscience (2025)
Open Access
Hydrogen Sulfide (H2S- or H2Sn-Polysulfides) in Synaptic Plasticity: Modulation of NMDA Receptors and Neurotransmitter Release in Learning and Memory
Constantin Munteanu, Anca‐Irina Galaction, Gelu Onose, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3131-3131
Open Access
Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology
Michal Korinek, M C Serra, Fes Abdel Rahman, et al.
Physiological Research (2024), Iss. Suppl 1, pp. S413-S434
Open Access | Times Cited: 3
Subtype-specific conformational landscape of NMDA receptor gating
Julia Bleier, Philipe Ribeiro Furtado de Mendonça, Chris Habrian, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114634-114634
Open Access | Times Cited: 3
Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction with Neurodegenerative Diseases
Moeka Nakashima, Naoko Suga, Sayuri Yoshikawa, et al.
(2024)
Open Access | Times Cited: 2
Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways
Ting Zhang, Chang Liu, Ning Zhong, et al.
(2024)
Open Access | Times Cited: 2
Structural and functional mechanisms of anti-NMDAR autoimmune encephalitis
Kevin Michalski, Taha Abdulla, S. N. Kleeman, et al.
Nature Structural & Molecular Biology (2024)
Closed Access | Times Cited: 2
Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways
Ting Zhang, Chang Liu, Ning Zhong, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10668-10668
Open Access | Times Cited: 2
Recent progress in understanding the intracellular domain's gating and functional roles in trimeric ligand-gated ion channels
Yan Lü, Yi-Yu Lin, Jin Wang
Journal of Zhejiang University (Medical Sciences) (2024)
Open Access | Times Cited: 1
Personalized epigenetics and neurological disorders
Bhawna Dahiya, Mahalaxmi Iyer, Tanja Maria Michel, et al.
Elsevier eBooks (2024), pp. 533-564
Closed Access
Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases
Moeka Nakashima, Naoko Suga, Sayuri Yoshikawa, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3922-3922
Open Access
Page 1

Scroll to top